Skip to content

Proactive Investors 5 February 2022

Artrya talks through its plan to bring its AI coronary heart disease diagnostic to the US

John Barrington AM talks to Proactive Investor about the company’s appointment of Dr. Jacque Sokolov as Chair of Artrya’s Clinical Advisory Board. Mr Barrington says Dr. Sokolov will help lead the group’s US clinical research program for its coronary heart disease diagnosis technology. He adds that Dr. Sokolov is a prominent cardiologist who has worked with more than 100 healthcare organisations in the US.